BioSpace News Archive

Medtronic plc, the global leader in medical technology, announced new data from the Micra Coverage with Evidence Development Study, the largest evaluation of leadless pacemakers to date, which showed the Micra™ Transcatheter Pacing System was associated with a 38% reduction in reinterventions and a 31% reduction in chronic complications at 2-years compared with traditional transvenous pacemakers.

Lynk Pharmaceuticals CO., LTD today announced that it has successfully completed Series B financing of $50 million , with Lilly Asia Ventures (LAV) as lead investor, New Alliance Capital and Hangzhou HEDA Biological Medicine Venture

Quanterix Corporation today released the following statement in response to news reports related to Cassava Sciences. Cassava previously engaged Quanterix’ Accelerator laboratory to perform sample testing based on blinded samples provided by Cassava. Quanterix or its employees did not interpret the test results or or prepare the data charts presented by Cassava at the Alzheimer’s Association International Conference (AAIC) in July 2021 or otherwise.

Immix Biopharma, Inc. (“ImmixBio”) today announced a clinical trial and supply agreement with BeiGene, Ltd. to evaluate the safety, tolerability and efficacy of combining IMX-110 with TME Normalization™ Technology

Registration is now open for the NORD Rare Diseases and Orphan Products Breakthrough Summit ®. The NORD Summit, one of the largest global events in rare disease, brings together experts and leaders from patient advocacy groups, government, industry, and academia to discuss the current and critical topics in rare diseases and orphan products.

Acasti Pharma Inc. (“Acasti”) (NASDAQ: ACST–TSX-V: ACST), announced today the completion of its previously disclosed acquisition of Grace Therapeutics, Inc. (“Grace”) via merger.

Bio-Thera Solutions, Ltd. and Hikma Pharmaceuticals PLC announced that they have entered into a commercialization and license agreement to commercialize BAT2206, a monoclonal antibody that is a proposed biosimilar referencing Stelara®, in the United States.

OsteoCentric Technologies, a pioneer of bone fixation in the orthopedic and dental space, has secured $30MM led by Squadron Capital and OnPoint Advisors.

Small Pharma Inc., a neuropharmaceutical company focused on psychedelic-assisted therapies, is pleased to announce that Ms. Lyne Fortin has been appointed non-executive independent chair of the board of directors of the Company.

Immutep Limited is pleased to announce the grant of patent no. ZL201580013695.X entitled “Antibody molecules to LAG-3 and uses thereof” by the Chinese Patent Office.